Michael received his PhD in biochemistry from the University in Frankfurt/Main, Germany. He was a Research Fellow and Instructor at the Dana-Farber Cancer Institute and Harvard Medical School in Boston, MA, working on vaccine design and antibody development. In recent years, he developed diagnostic antibodies for blood tests.